FFL
NVO

Financial Freedom LLC’s Novo Nordisk NVO Stock Holding History

Financial Freedom LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-115
Closed -$4.22K – 298
2026
Q1 		$4.22K Hold
115
– – ﹤0.01% 365
2025
Q4 		$5.85K Hold
115
– – ﹤0.01% 293
2025
Q3 		$6.38K Hold
115
– – ﹤0.01% 303
2025
Q2 		$7.93K Hold
115
– – ﹤0.01% 290
2025
Q1 		$7.98K Hold
115
– – ﹤0.01% 292
2024
Q4 		$9.89K Hold
115
– – 0.01% 274
2024
Q3 		$13.7K Hold
115
– – 0.01% 250
2024
Q2 		$16.4K Buy
+115
New +$15.2K 0.01% 237

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Financial Freedom LLC's NVO Position: Q2 2026 in Review

Financial Freedom LLC sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 115 shares — an estimated $4.22K sold.

Financial Freedom LLC first reported a position in NVO in Q2 2024 and held it in 8 quarters. The position peaked at $16.4K in Q2 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Financial Freedom LLC reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Financial Freedom LLC sold 115 Novo Nordisk shares in Q2 2026, an estimated $4.22K.
  • Financial Freedom LLC first reported a position in Novo Nordisk in Q2 2024 and held it in 8 quarters.
  • Financial Freedom LLC's Novo Nordisk position peaked at $16.4K in Q2 2024.
  • 1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.